Journal of Managed Care Pharmacy Recognizes Prime Therapeutics With Two 2012 JMCP Award for Excellence Honorable Mentions
5/7/2013 9:53:58 AM
More...
|
Prime Therapeutics, in Partnership With North Dakota State University, Receives Research Grant From National Association of Chain Drug Stores Foundation
4/9/2013 9:25:56 AM
More...
|
Prime Therapeutics Names Glen Laschober as Chief Operating Officer
4/8/2013 11:03:13 AM
More...
|
Prime Therapeutics Release: Studies Show Increasing Costs and Potential for Significantly Higher Use of Specialty Drugs to Treat Inflammatory Autoimmune Conditions
4/4/2013 10:04:23 AM
More...
|
Prime Therapeutics Appoints Ellyn Hosch as Chief Information Officer
4/3/2013 9:42:35 AM
More...
|
Prime Therapeutics Release: Specialty Drug Costs Account for More Than 50 Percent of the Total Cost of Care for Rheumatoid Arthritis and Hepatitis C Patients
4/2/2013 3:30:41 PM
More...
|
Prime Therapeutics Release: Specialty Drugs Will Account for 50 Percent of All Drug Costs by 2018
4/2/2013 3:28:56 PM
More...
|
Prime Therapeutics Earns CEO Cancer Gold Standard Accreditation
2/25/2013 11:23:39 AM
More...
|
Prime Therapeutics Named a 2013 National Top Workplace
1/31/2013 9:22:41 AM
More...
|
Prime Therapeutics Names Ann Tobin as Chief Compliance Officer
1/28/2013 9:15:29 AM
More...
|
|